Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Positive Testimony Doesn’t Seem to Help Bank of America Corp (BAC) Stock

Shares of Bank of America Corp (NYSE:BAC) are essentially flat today as investors remain weary over a critical legal hearing involving the lender that’s currently underway in New York City. Roughly an hour into the trading session, nation’s second largest bank by assets is up by $0.01, or 0.07%.

Bank of America Corp (NYSE:BAC)

Bank of America Corp (NYSE:BAC) has moved aggressively this year to clean up the legal liability that’s weighed on its stock since the financial crisis. In January, it announced a massive settlement with Fannie Mae. In April, it followed suit by taking care of multiple class action lawsuits related to securities fraud. And in May, it put the particularly contentious dispute with mortgage-bond insurer MBIA Inc. (NYSE:MBI) behind both of the companies, sending shares of the latter skyrocketing on the news.

Although there are still a handful of remaining cases to deal with, none is more important than the one that’s currently before a judge in New York state court. At issue in the hearing is whether or not Bank of America Corp (NYSE:BAC)’s $8.5 billion accord with Bank of New York Mellon Corporation (NYSE:BK) and 22 institutional investors, including bond giants BlackRock, Inc. (NYSE:BLK) and PIMCO, should be judicially approved. While the deal was reached in 2011, it’s been held up by other investors in the same mortgage-backed securities because they view it as a “pennies on the dollar” bargain for Bank of America Corp (NYSE:BAC).

So far, few salacious details have emerged from the hearing, which got under way at the beginning of last week. As I discussed here, the most interesting thing investors have learned is that Bank of America Corp (NYSE:BAC) not only considered putting the maligned Countrywide Financial into bankruptcy, but that it went so far as to get approval to do so from its primary regulator, the Office of the Comptroller of the Currency. The significance of this speaks to whether or not Bank of America Corp (NYSE:BAC) is, in fact, legally obligated to cover Countrywide’s liabilities.

The latest news to emerge came from testimony on Friday about how at least one of the parties to the agreement viewed the deal. According to PIMCO’s Kent Smith, an executive vice president at the California-based asset manager, the deal was “outstanding” and is in the “best interest of our clients to support it.” Suffice it to say, while this is only one statement from one witness in the sure-to-be extenuated legal hearing, it’s nevertheless a nice endorsement for Bank of America to have in its corner given that PIMCO is one of the largest and most sophisticated financial firms in the world.

The article Positive Testimony Doesn’t Seem to Help Bank of America Stock originally appeared on

John Maxfield owns shares of Bank of America. The Motley Fool recommends BlackRock. The Motley Fool owns shares of Bank of America.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.